Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-07-28 00:00:00 ET · period of report 2023-07-27 · accession 0001104659-23-085087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | 2023-07-27 | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $13.98 | +1,556 | 2.59M | +0.1% | +$21.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-27 | P | A | 1,556 | $13.98 | 2,591,556 | D | — | — |